Clinical trials
Phase 2 Huntington Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 4 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 4 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| Pfizer | 2 |
| Prilenia | 2 |
| Supernus Pharmaceuticals, Inc. | 2 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 2 |
| University of Iowa | 2 |
| University of Rochester | 2 |
| Annexon, Inc. | 1 |
| Azevan Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huntington Disease | 28 |
| Chorea | 6 |
| Attention Deficit Disorder with Hyperactivity | 2 |
| Neurodegenerative Diseases | 1 |
| Prodromal Symptoms | 1 |
| Rare Diseases | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.